Tribeca Knowledge

FEBRUARY 24, 2021

I t is probably reasonable enough by now to talk about the launch readiness landscape for medicines and vaccines as pre- and post-COVID. We can also say with some certainty that nothing will ever be the same again.

Medicine 52

Medicine Pharma 52

PharmExec

JANUARY 19, 2023

Launch Ready from Day One is designed to empower a company's customer facing teams to drive demand, simplify access, and create a seamless and more integrated customer experience.

Training 52

Training Biopharma 52

PharmaTech

APRIL 16, 2024

WMFTS has launched WMArchitect, a single-use product line that offers ready-to-use single-use assemblies and custom-designed workflows for biopharma fluid management.

Management 52

Management Biopharma 52

Tribeca Knowledge

DECEMBER 8, 2022

As we map out in our pharma trends for 2023, COVID-related disruption has created a whole new set of launch readiness and market access challenges for companies looking to maximise their assets in the new year. T he pharmaceutical industry has little room for complacency in a post-COVID world.

Pharma 96

Pharma Pharmaceutical Marketing 96

Pharmaceutical Technology

OCTOBER 20, 2023

The company has said that it is ready to launch a Phase IIa trial with the drug being intended to treat an often painful condition.

52

52

World of DTC Marketing

DECEMBER 9, 2021

The days of enormous product launch budgets are over unless a new mass-market product is introduced. One top-10 pharma company has created a “market launch metric” team to measure key launch milestones. ” The post Do you have enough money to launch your drug?

Media 204

Media Physicians Marketing Pharma 204

World of DTC Marketing

APRIL 19, 2022

Before most drugs are launched, much time and effort are spent developing marketing plans and getting approval. Brand managers usually spend a lot of meetings getting approval for product launches, but that could be a huge mistake. You’re on top of trends that will affect your brand’s launch or growth in its life cycle.

Marketing 192

Marketing Media Healthcare Healthcare 192

PM360

NOVEMBER 12, 2023

Here’s the fact: since the pandemic, launch revenues in pharma have declined. The question is: What do you do to maximize the success of your launch? In my experience, enormous respect must be paid to the pre-launch market research that assesses the impact your brand will make on the market. Those insights are irreplaceable.

Physicians 64

Physicians Marketing Sales Pharma 64

Pharmaceutical Technology

JUNE 15, 2023

The US Food and Drug Administration (FDA) has approved Amneal Pharmaceuticals’ 505(b)(2) new drug application (NDA) for a ready-to-use oncology injectable, PEMRYDI RTU. Amneal Pharmaceuticals claimed that PEMRYDI RTU is the first and only ready-to-use presentation of pemetrexed for injection.

Food and Drug Administration 52

Food and Drug Administration FDA Food Pharmaceutical 52

European Pharmaceutical Review

MAY 23, 2023

“Emerging biotech companies responsible for a record 65 percent of the molecules in the R&D pipeline in 2022” made common infrastructure choices to prepare for a European launch, stated Isma Hachi, Director Emerging Biopharma for IQVIA.

Biopharma 112

Biopharma Government Pharma Medicine 112

World of DTC Marketing

JULY 30, 2021

When I worked on the launch of Cialis, our digital agencies were always available via IM. If you have a good agency, you should be sharing it with your colleagues and promoting them within your company so that when a new brand is ready to launch, selecting an agency is 90% done. This was a huge benefit for us.

Media 286

Media Prescription Pharma Prospecting 286

Contrarian Sales Techniques

DECEMBER 20, 2023

A data alchemist, transforming numbers into dazzling displays and irresistible product launches. Here, strategic plans waltz with data analysis, while product launches pirouette under the spotlight of innovative thinking. So, are you ready to swap spreadsheets for swatches, data reports for dazzling displays?

Sales 52

Sales Retail Marketing Management 52

World of DTC Marketing

AUGUST 13, 2020

While most offices remain closed pharma is preparing for the launch of new products and has to have the infrastructure to ensure a successful launch. Obviously the experience can vary wildly between companies but it’s a good time if you want to learn and are ready to challenge the status quo.

Pharma 223

Pharma Doctors Media Prescription 223

World of DTC Marketing

SEPTEMBER 30, 2020

HERE”S THE DEAL: Determining how much to spend for the launch of a new drug is a challenge we all face and you have to be ready to shift funds from channels that are failing to provide the lift in brand awareness to channels that hit the bullseye on your objectives. The post Launching a new drug: How much to spend on DTC?

Media 180

Media Marketing Sales Leads 180

PM360

NOVEMBER 29, 2022

As healthcare marketers, we often focus on the official launch of a new product as a pinnacle moment for its commercial success. But in many cases, success depends on actions taken before the launch date—specifically, how well the market has been primed to receive a novel product. Avoid overly promotional messaging.

Marketing 98

Marketing Healthcare Healthcare Education 98

PM360

APRIL 22, 2024

Understanding the “why” before the “how” as Med Affairs charts the course for pre- and post-launch strategies. With a focus on patient-centricity, data-driven insights, and collaborative partnerships across the healthcare ecosystem, it’s redefining the playbook for market shaping and building advocacy for a product pre- and post-launch.

Medical 52

Medical Healthcare Healthcare Education 52

Medico Reach

JULY 3, 2022

With so much at stake, all stakeholders must work cooperatively to ensure the product launch is a success. In that case, an effective product launch plan will help it overcome most of the market’s obstacles. The post will outline the successful steps for medical device product launch. Establish Launch Objectives.

Medical 97

Medical Food and Drug Administration Training Marketing 97

Medical Device Success

JULY 4, 2021

The right evidence powers you through your regulatory process and aligns that process and your claims with your value propositions across stakeholders and then on through your product launch. TTi Health Research & Economics Market Readiness Assessment link. TTi Health Research & Economics Market Readiness Assessment link.

Marketing 130

Marketing Medical Sales 130

European Pharmaceutical Review

FEBRUARY 7, 2024

The site will launch the company’ s cell therapy platforms in the US for critical cancer trials and future commercial supply. AstraZeneca has announced a $300 million investment in a US-based manufacturing facility in Rockville, Maryland, which will focus initially on T-cell therapies for oncology indications.

Manufacturing 83

Manufacturing Medicine Networking Patients 83

Clarify Health

FEBRUARY 7, 2023

They were looking for ways to launch high-performing provider networks more efficiently and needed to quickly assess provider performance in 12 new markets. Using Clarify Networks, a cloud-based software that optimizes networks for market success , this organization was ready to enter all 12 new markets in just 3 months.

Networking 52

Networking Marketing 52

Pharmaceutical Technology

JUNE 21, 2023

Ketarx will be marketed under the FDA-approved label of ketamine and in dosages that include 10mg/ml, 50mg/ml and 100mg/ml, with the option to boost the concentration and ready-to-administer applications. Ketarx will then be commercially launched in the second quarter. Ketamine is currently on the FDA’s drug shortage list.

Distribution 52

Distribution FDA Specialization Sales 52

World of DTC Marketing

JANUARY 4, 2021

DTC marketers need to be ready to understand and help patients who request new medications via telehealth or email. They should not rely on a “digital team” who meets with the brand to launch digital initiatives. Become the “go-to” health site for new health information on the condition in which you compete.

Marketing 271

Marketing Media Medical Prescription 271

PM360

JUNE 29, 2022

For example, if you are within a year of launch, embarking on a bold, novel launch strategy is likely not going to provide you with enough time to course correct if challenges arise. If you are not ready today, then determine how you will get ready for tomorrow. Use this to your advantage. Honesty is the best policy here.

Medicine 105

Medicine Marketing Pharma Competition 105

European Pharmaceutical Review

DECEMBER 20, 2023

Though extensions are possible, extension criteria could be challenging to achieve in practice (eg, pan-EU launch within two years, proof of unmet need). The first is removal of the RDP extension for pan-EU launch within two years, instead requiring manufacturers to submit to local P&MA processes upon request by the member state.

Biopharma 85

Biopharma Pharmaceutical Medicine Manufacturing 85

European Pharmaceutical Review

OCTOBER 4, 2022

Results from the pilot are anticipated to be ready in three to four years, when a report will be issued and a workshop with relevant stakeholders will discuss the lessons learned and what support measures or regulatory changes should be made going forward.

Medicine 89

Medicine Manufacturing Patients Medical 89

World of DTC Marketing

MAY 3, 2022

2wo: The competition’s MS drugs were better – The MS market is lucrative, and competitors launched products that were better than Biogen’s with fewer side effects discussed by the MS community online. A new CEO will be appointed and will undoubtedly be charged with getting the company ready for sale.

Side effects 207

Side effects FDA Media Pharma 207

Pharmacy Times

JUNE 14, 2023

- Adds first ready-to-use presentation of key injectable for treating non-squamous non-small cell lung cancer and malignant pleural mesothelioma. Represents a high value, complex product launch for Amneal’s expanding injectable portfolio.

FDA 26

FDA 26

Pharmaceutical Technology

JUNE 8, 2023

Our strong manufacturing capability and scale, including from our vaccine manufacturing site in Belgium, means we are ready to deliver the vaccine as countries begin to launch.” The marketing authorisation from the EC was supported by data obtained from a pivotal Phase III AReSVi-006 (adult respiratory syncytial virus) trial.

Food and Drug Administration 59

Food and Drug Administration Marketing Manufacturing Medicine 59

Legacy MEDSearch

NOVEMBER 22, 2022

The company expects to launch the VisionPort System in the US before the end of 2022. This is the first time that I have launched a product that adds value across all stakeholders, clinical and financial alike in such a profound way. New View Surgical, Inc., For more information, please visit www.newviewsurg.com. Closes $12.1M

Marketing 98

Marketing Recruitment Medical Management 98

Pharmaceutical Technology

NOVEMBER 8, 2022

Following the acquisition, Viatris will combine its research and development (R&D), international commercial footprint and regulatory expertise and supply chain with the deep expertise of Oyster Point in the ophthalmology space, as well as Phase III-ready pipeline of Famy Life Sciences.

Food and Drug Administration 59

Food and Drug Administration Leads Pharma Food 59

Nixon Gwilt Law

JANUARY 23, 2023

Are you getting ready to launch an RTM offering or wondering if you should add a CCM or PCM service line to your existing revenue model? Click here to download the Medicare Non-Facility Reimbursement Chart for Care Management Services.

Management 52

Management Physicians Healthcare Healthcare 52

Contrarian Sales Techniques

DECEMBER 20, 2023

So, are you ready to trade the lab coat for a sales blazer? Are you ready to unleash your scientific spirit and become a healthcare champion in Ipoh? With dedication and your science-fueled drive, you can climb the ranks, shape the future of healthcare in Ipoh, and become a legend in the medical sales scene. Good luck!

Sales 40

Sales Healthcare Healthcare Medical sales 40

Pharmaceutical Technology

APRIL 21, 2023

Our distribution partners have Cuvrior stocked and ready for immediate use. At Orphalan, our focus is on providing targeted solutions for rare diseases, as demonstrated by the successful launch of Cuprior in Europe.”

Food and Drug Administration 52

Food and Drug Administration Transportation Distribution Prospecting 52

Contrarian Sales Techniques

DECEMBER 19, 2023

So, are you ready to ditch the textbooks and grab the scientific baton? Are you ready to trade the lab bench for the sales stage and ignite your career with purpose and passion? If the answer is a resounding "Yes!", Good luck!

Medical sales 40

Medical sales Sales Medical Doctors 40

European Pharmaceutical Review

NOVEMBER 28, 2022

FACILITATE , (FrAmework for ClInicaL trIal participants’ daTA reutilisation for a fully Transparent and Ethical ecosystem) is a patient-driven legal framework that intends to help return clinical trial data to study participants, ready for re-use in further research or healthcare practice.

Patients 94

Patients Ethics Pharmaceutical Management 94

Clarivate

DECEMBER 9, 2022

To help you get ready, we created a simple checklist of five steps you can take to prepare. Before the Unitary Patent goes live: The UPC announced a three-month sunrise period will precede the launch of the UP and UPC. Clarivate stands ready to help you navigate the new Unitary Patent system. Monitor UPC case law.

Management 52

Management 52

PM360

MAY 4, 2023

We are laser-focused on launching new, innovative solutions to further bring our vision to life,” said Rotsart. The recognition has further ignited the award-winner’s readiness and commitment to doing more. Operations at Adheris Health.

Retail 52

Retail Medical Patients Networking 52